Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer-sponsored clinical trial evaluating enzalutamide versus abiraterone in metastatic castration-resistant prostate cancer has completed …
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the safety and activity of BPX-601, a PSCA-targeted CAR-T cell therapy, in selected advanced solid tumors including…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer [Phase 1]
A Phase 1 clinical trial to evaluate the safety and drug levels of ASP5541 in Chinese participants with prostate cancer is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study of ACTinium in metastatic castration-resistant prostate cancer following prior …
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs [NA]
A completed clinical trial update investigating microRNA expression as predictive factors for treatment resistance in metastatic castration-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors [Phase 2]
A Phase 2 study evaluating vobramitamab duocarmazine in metastatic castration-resistant prostate cancer and other solid tumors was terminate…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating the combination of pertuzumab, trastuzumab, hyaluronidase-zzxf, and enzalutamide for metastatic …
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial of Erdafitinib in castration-resistant prostate cancer was terminated; the document provides the status update without repor…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]
This early-phase Phase 1 trial evaluates the safety and preliminary efficacy of combining LC-K76 with an anti-PD-1 therapy in patients with …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer [Phase 1]
Phase 1 safety and dose-finding study of PRL-02 Depot in men with advanced prostate cancer is currently recruiting, indicating early clinica…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]
This Phase 1 trial evaluates the safety, tolerability and preliminary efficacy of the PSMA-targeted radioligand 161Tb-LNC1011 in patients wi…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer-sponsored real-world evidence study on metastatic prostate cancer (metastatic castration-sensitive and metastatic castration-resistan…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating apalutamide with or without stereotactic body radiation therapy in castration-resistant prostate cancer completed, …
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Efficacy of Ra-223 in PSMA PET Optimally Selected Patients [Phase 2]
Phase 2 trial update evaluating the efficacy of Radium-223 dichloride in PSMA PET–selected patients with castration-resistant, metastatic pr…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
This clinical trial update reports termination of a study evaluating urokinase plasminogen activator receptor in abiraterone-treated castrat…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment [Phase 3]
Phase 3 trial evaluating Lu-177 labeled PSMA-targeted radioligand PNT2002 for metastatic castration-resistant prostate cancer after second-l…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel [Phase 2]
Phase 2 trial update evaluating abiraterone acetate with or without cabazitaxel and prednisone in metastatic castration-resistant prostate c…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC [Phase 2]
A Phase 2 trial evaluating the combination of cabozantinib with abiraterone in chemotherapy-naïve, bone-metastatic castration-resistant pros…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: 177Lu-HTK03170 in mCRPC With PSMA Positive Disease [Phase 1, Phase 2]
Trial update for a Phase 1/2 study of the radiopharmaceutical 177Lu-HTK03170 in metastatic castration-resistant prostate cancer; recruitment…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer [Phase 2]
Phase 2 trial of ipilimumab plus nivolumab in molecularly selected castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Post Marketing Study on Pluvicto in Korea
A post-marketing study of Pluvicto (Lutetium-177-PSMA-617) in Korea for metastatic castration-resistant prostate cancer is currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]
Phase 1 safety and tolerability study of CC-94676 in metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations [Phase 4]
A Phase 4 clinical trial evaluating olaparib for efficacy and safety in Chinese patients with metastatic castration-resistant prostate cance…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) [Phase 2]
Completed Phase 2 study evaluating cabozantinib in metastatic castration-resistant prostate cancer (mCRPC).
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial assessed the combination of talazoparib and temozolomide in prostate cancer, including castration-resis…